Skip to main content
TipRanks
Go Ultimate75% OFF

Reviva Pharmaceuticals Holdings (RVPH) Stock Forecast & Price Target

1,273 Followers
See the Price Targets and Ratings of:

RVPH Analyst Ratings

Currently, no data available

RVPH Stock 12 Month Forecast

There Are No Analyst Ratings for RVPH In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for RVPH
Price TargetArticle
Alliance Global Partners$30buy7631.96%UpsideReiterated05/21/26
Maxim Group―hold―Downgraded04/08/26
Roth MKM$1.50→$1buy157.73%UpsideAssigned04/01/26
D. Boral Capital―hold―Downgraded03/05/26
Chardan Capital$40buy10209.28%UpsideReiterated01/05/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
DFTXDefinium Therapeutics
RDNTRadnet
AXGNAxoGen
PLSEPulse Biosciences
AHCOAdaptHealth

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Reviva Pharmaceuticals Holdings

3 Months
James Molloy
James MolloyAlliance Global Partners
Success Rate2/6 ratings generated profit
33%
Average Return
-15.73%

Copying James Molloy's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -15.73% per trade.

1 Year
James Molloy
James MolloyAlliance Global Partners
Success Rate1/6 ratings generated profit
17%
Average Return
-47.65%

Copying James Molloy's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -47.65% per trade.

2 Years
James Molloy
James MolloyAlliance Global Partners
Success Rate0/6 ratings generated profit
0%
Average Return
-62.30%

Copying James Molloy's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -62.30% per trade.

RVPH Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for RVPH
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy10000
Buy00000
Hold10000
Sell00000
Strong Sell00000
total20000

In the current month, RVPH has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RVPH average Analyst price target in the past 3 months is ―.

RVPH Financial Forecast

$-2$-1.25$-0.5$0.25$1Q1 2026Q3 2026Q4 2026
High$-0.16
Consensus$-0.29
Low$-0.41

RVPH Earnings Forecast

Next quarter’s earnings estimate for RVPH is -$0.29 with a range of -$0.41 to -$0.16. The previous quarter’s EPS was -$0.17. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q1 2026Q3 2026Q4 2026
High$0.00
Consensus$0.00
Low$0.00

RVPH Sales Forecast

Next quarter’s sales forecast for RVPH is $0 with a range of $0 to $0. The previous quarter’s sales results were ―. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

RVPH Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Reviva Pharmaceuticals Holdings?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of RVPH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.